Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy. [electronic resource]
Producer: 20121212Description: 283-92 p. digitalISSN:- 1423-0216
- Adult
- Analysis of Variance
- CD4 Antigens -- metabolism
- Cell Proliferation -- drug effects
- Disability Evaluation
- Dopamine -- pharmacology
- Female
- Forkhead Transcription Factors -- genetics
- Gene Expression Regulation -- drug effects
- Humans
- Immunologic Factors -- therapeutic use
- Interferon-beta -- therapeutic use
- Interleukin-2 Receptor alpha Subunit -- metabolism
- Male
- Middle Aged
- Multiple Sclerosis, Relapsing-Remitting -- drug therapy
- Phytohemagglutinins
- RNA, Messenger
- Receptors, Dopamine D3 -- genetics
- Receptors, Dopamine D5 -- genetics
- Severity of Illness Index
- Statistics, Nonparametric
- T-Lymphocytes, Regulatory -- drug effects
- Tyrosine 3-Monooxygenase -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.